Considerations on the use of sulfones and sulfamides with a pyrimidine derivative by the malaria control service of Mocambique.
D000293:Adolescent; D000655:Amodiaquine / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003140:Communicable Disease Control; D003622:Dapsone / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007223:Infant; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D009073:Mozambique; D011319:Primaquine / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D013607:Tablets
D000962:Antimalarials; D004338:Drug Combinations; D011743:Pyrimidines; D013449:Sulfonamides; D013450:Sulfones; D013607:Tablets; D000655:Amodiaquine; D003622:Dapsone; D011319:Primaquine; D011739:Pyrimethamine